RECRUITING

Protocol for Women at Increased Risk of Developing Breast Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.

Official Title

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

Quick Facts

Study Start:1989-08
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00291096

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 65 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * women with at least 2 times the normal risk of developing breast cancer
  2. * between the ages of 30-65 (or within 10 years of youngest age at diagnosis in first degree relative)
  3. * greater than six months from ingestion of antihormonal therapy
  4. * greater than 1 year from pregnancy, lactation, or chemotherapy
  5. * willing to have a mammogram within six months prior to RPFNA
  6. * willing to discontinue NSAIDS or herbal supplements
  7. * willing to have blood drawn
  1. * no metastatic malignancy of any kind
  2. * no breast implants or tram flap reconstructions
  3. * no radiation to both breasts
  4. * no women who have a current mammogram or clinical breast exam suspicious for cancer

Contacts and Locations

Study Contact

Bruce Kimler, Ph.D.
CONTACT
913-588-4523
bkimler@kumc.edu

Principal Investigator

Carol J Fabian, MD
PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center

Study Locations (Sites)

University of Kansas Medical Center
Kansas City, Kansas, 66160
United States

Collaborators and Investigators

Sponsor: Carol Fabian, MD

  • Carol J Fabian, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date1989-08
Study Completion Date2026-12

Study Record Updates

Study Start Date1989-08
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • breast atypia
  • fine needle aspiration
  • high risk for breast cancer
  • breast epithelial hyperplasia

Additional Relevant MeSH Terms

  • Breast Cancer